• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NanoViricides, Inc. Common Stock (NY:NNVC)

    1.450 +0.150 (+11.54%)
    Streaming Delayed Price Updated: 12:07 PM EDT, May 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about NanoViricides, Inc. Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    News headline image
    Booster Shots Might Not Be Enough to Beat Omicron, According to Some Nanotech Experts ↗
    Image provided by Pixabay This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. As the threat... 
    Via Benzinga
    News headline image
    NanoViricides Attempts to Leverage Decades of Combined Pharmaceutical and Biotech Experience To Bring Broad-Spectrum COVID-19 Antiviral to Market ↗
    Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
    Via Benzinga
    News headline image
    NanoViricides Says Its Nanomedicine Tech Could Be the Key To Defeating Omicron and Other COVID-19 Variants ↗
    Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
    Via Benzinga
    News headline image
    These Biotech Companies Are Attempting to Use Improved Antibody Technology in the Fight To Eradicate COVID-19 ↗
    Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
    Via Benzinga
    News headline image
    NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards Clinical Trials
    SHELTON, CT / ACCESSWIRE / November 16, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel... 
    From NanoViricides, Inc.
    Via AccessWire
    Topics Regulatory Compliance
    News headline image
    EXCLUSIVE: NanoViricides Completes Oral Gummies, Lung Inhalation Formulations For COVID-19 Treatment ↗
    NanoViricides, Inc. (NYSE: NNVC) announced Monday it has developed an oral gummies formulation of its COVID-19 Drug Candidate NV-CoV-2 to benefit non-hospitalized... 
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
    Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday! 
    Via InvestorPlace
    News headline image
    NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2
    SHELTON, CT / ACCESSWIRE / November 15, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel... 
    From NanoViricides, Inc.
    Via AccessWire
    News headline image
    EXCLUSIVE: NanoViricides Develops Chewable Pills, Lung Inhalation Formulations For COVID-19 Candidate ↗
    NanoViricides Inc (NYSE: NNVC) has developed oral gummies formulations of its Pan-Coronavirus COVID-19 Drug Candidate NV-CoV-2 to benefit non-hospitalized patients. What... 
    Via Benzinga
    News headline image
    Todos Medical Says It Wants to Outfox COVID-19 & Cancer Along With Rivals Pfizer & Merck With New Theranostic Approach ↗
    Photo by Artem Podrez from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
    Via Benzinga
    News headline image
    Are Pfizer, Moderna, J&J Booster Shots a Panacea? This Company Says Its Broad-Spectrum Drugs to Fight COVID-19 Would Help End the Pandemic ↗
    Photo by Steven Cornfield on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
    Via Benzinga
    News headline image
    NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage
    SHELTON, CT / ACCESSWIRE / October 13, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2021... 
    From NanoViricides, Inc.
    Via AccessWire
    Topics Intellectual Property Regulatory Compliance
    News headline image
    NanoViricides COVID-19 Treatment Candidate Found Effective Against Coronavirus Variants In Lab Study ↗
    Shares of NanoViricides Inc (NYSE: NNVC), a developer of antiviral therapies based on a novel nanomedicines technology, are higher Monday. What Happened: NanoViricides... 
    Via Benzinga
    Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
    Palm Beach, FL –October 11, 2021 – FinancialNewsMedia.com News Commentary – With the arrival of the COVID-19 virus, the antivirals market had all eyes watching the ongoing frenetic rush to find a cure... 
    Via FinancialNewsMedia
    News headline image
    NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity ↗
    Shelton, Connecticut -- (October 11, 2021) - NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral... 
    Via Benzinga
    News headline image
    NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity
    SHELTON, CT / ACCESSWIRE / October 11, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel... 
    From NanoViricides, Inc.
    Via AccessWire
    News headline image
    NanoViricides Leaps Forward in its Quest to Defeat COVID-19 ↗
    Photo by Louis Reed on Unsplash Since the coronavirus pandemic started, scientists have worked to develop a vaccine to inoculate the population and stop the spread of COVID-19.... 
    Via Benzinga
    News headline image
    31 Stocks Moving In Monday's Mid-Day Session ↗
    Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to... 
    Via Benzinga
    News headline image
    20 Stocks Moving in Monday's Pre-Market Session ↗
    Gainers Puhui Wealth Investment Management Co., Ltd. (NASDAQ: PHCF) rose 49% to $3.65 in pre-market trading. Paltalk, Inc. (NASDAQ: PALT) rose 43.9% to $5.77 in pre-market... 
    Via Benzinga
    News headline image
    50 Biggest Movers From Yesterday ↗
    Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a... 
    Via Benzinga
    News headline image
    32 Stocks Moving In Wednesday's Mid-Day Session ↗
    Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share... 
    Via Benzinga
    News headline image
    Nanoviricides Stock Surges, Nears The End Of A Pennant Pattern ↗
    Nanoviricides Inc. (NYSE:NNVC) shares are surging higher Tue... 
    Via Benzinga
    News headline image
    What Is a ‘News Pending’ Halt? What to Know as NNVC Stock Captivates Investors ↗
    Today, NanoViricides is grabbing a lot of attention due to a news pending halt that has sent NNVC stock skyrocketing. 
    Via InvestorPlace
    News headline image
    EXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile ↗
    NanoViricides Inc (NYSE: NNVC) has reported significant advantages gained by remdesivir encapsulation within its lead COVID-19 candidate, thus showing a potential pan-... 
    Via Benzinga
    News headline image
    53 Biggest Movers From Yesterday ↗
    Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation... 
    Via Benzinga
    Topics Initial Public Offering
    News headline image
    38 Stocks Moving In Wednesday's Mid-Day Session ↗
    Gainers Indaptus Therapeutics, Inc. (NASDAQ: INDP) shares jumped 177.2% to $19.60 after the company announced the United States Patent and Trademark Office has issued a notice of... 
    Via Benzinga
    Topics Intellectual Property
    News headline image
    26 Stocks Moving in Wednesday's Pre-Market Session ↗
    Gainers Nxt-ID, Inc. (NASDAQ: NXTD) rose 46.1% to $0.6699 in pre-market trading after dropping 11% on Tuesday. MeaTech 3D Ltd. (NASDAQ: MITC) rose 18.5% to $6.29 in pre-market... 
    Via Benzinga
    News headline image
    46 Biggest Movers From Yesterday ↗
    Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited... 
    Via Benzinga
    News headline image
    Why Nanoviricides' Stock Is Trading Higher Today ↗
    Nanoviricides (AMEX:NNVC) shares are trading higher after the company announced it completed the process of licensing the human Coronavirus field for drug development and... 
    Via Benzinga
    News headline image
    36 Stocks Moving In Tuesday's Mid-Day Session ↗
    Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.